Quote this publication Share Print


Opinions on drugs - Posted on May 21 2013

Reason for request

Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.


Clinical Benefit


The actual benefit of MIRCERA is substantial.

Clinical Added Value

no clinical added value

MIRCERA offers no improvement in actual benefit (level V) compared to the other
erythropoiesis-stimulating agents that are indicated in the correction of anaemia associated with chronic kidney disease.

Contact Us

Évaluation des médicaments